
Nopion 150 Tablet ER
Marketer
Holy Evolution Pharma
Salt Composition
Bupropion (150mg)
Overview Nopion 150 Tablet ER
Nuplazid 150mg Extended-Release Tablets are indicated for managing depressive disorders and nicotine dependence. The medication's mechanism involves elevating neurotransmitter levels, promoting neural relaxation and a calming cerebral effect. Nuplazid 150mg ER tablets can be administered with or without food, consistently at the same time daily. Complete the prescribed course, even with symptom improvement; discontinuing abruptly may exacerbate conditions. Potential adverse effects include sleep disturbances, allergic responses, cognitive impairment, diaphoresis, cephalalgia, nausea, emesis, and xerostomia. Drowsiness and vertigo are also possible, precluding operation of machinery or activities demanding concentration. While most side effects are transient and self-limiting, persistent or bothersome symptoms warrant medical attention. Prior to commencing treatment, disclose any history of seizures or alcohol consumption. Report any unusual shifts in mood or suicidal ideation immediately to your physician.
Uses of Nopion 150 Tablet ER
Tobacco dependence and depressive disorder
Major Benefits of Nopion 150 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Nopion 150 Tablet ER. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of Nopion 150 Tablet ER:
- Insomnia (difficulty in sleeping)
- Allergic reaction
- Impaired concentration
- Sweating
- Headache
- Nausea
- Vomiting
- Dizziness
- Dryness in mouth
- Taste change
- Abdominal pain
- Agitation
- Anxiety
- Fever
- Constipation
- Tremors
How to use Nopion 150 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Nopion 150 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
How Nopion 150 Tablet ER works:
Extended-release Nopion 150 mg tablets treat depression by elevating neurotransmitter concentrations, thereby improving mood regulation. The precise mechanism by which it aids smoking cessation remains unclear.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Nopion 150 ER tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Nopion 150mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the treatment's advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCAUTION
Extended-release Nopion 150 mg tablets require careful consideration when breastfeeding. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Extended-release Nopion 150mg tablets can induce adverse reactions that impair driving capabilities. These reactions may include dizziness, lightheadedness, and diminished concentration and judgment, potentially affecting the ability to operate a vehicle safely.
KidneyCAUTION
Extended-release Nopion 150 mg tablets require careful administration for individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Nopion 150 ER tablets. Dosage modification may be necessary. Physician consultation is recommended. Close medical supervision is advisable for patients with liver disease to monitor for potential adverse reactions.
What if you forget to take Nopion 150 Tablet ER :
Omit any missed Nopion 150mg Extended-Release tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nopion 150 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Propiophenone Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Behavior Class | Norepinephrine and dopamine reuptake inhibitor |
